06 December 2003
Organ donor with cerebellar medulloblastoma: a case report and review of the literature.
Agnieszka Hałoń, Dariusz D Patrzałek, Jerzy J RabczyńskiAnn Transplant 2002; 7(1): 15-19 :: ID: 5563
Abstract
Transplantation of organs and tissues procured from brain-dead organ donor (BDOD) is nowadays a common and desirable therapy for end-stag organ failure, especially kidneys, liver and heart. The majority of organs for transplantation are obtained from individuals with massive and irreversible central nervous system injury. This group of organ donors is however unsatisfactory and small according to needs. Significant percentage of multiorgan donors could be found among patients suffering from primary cerebral neoplasms as these rarely metastasize spontaneously outside the central nervous system. The paper presents the case of a 30-year-old male donor with a central nervous system tumor. Histogenesis, pathway of malignant dissemination, prognosis and the use of organ donor with cerebellar medulloblastoma are also discussed.
Keywords: Medulloblastoma - etiology
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






